Reading your post, I was reminded of the key appointment by Neuren of Dr Clive Blower back in June 2014. The appointment of a Vice-President for Product Development and Technical Affairs could easily have passed without public comment yet was deemed worthy of an announcement;
Neuren Appoints CMC Expert to Leadership Team
Your post clearly and cleverly clarifies the importance of the appointment. Commenting on the announcement Richard Treagus said;
"[Clive] brings a very broad technical pharmaceutical knowledge and a rare level of hands-on experience interacting with global contract manufacturers and the FDA."
Leaving nothing to chance, building on every opportunity, progressing purposefully towards Breakthrough Therapy designation as well as building "preparedness for dealing with global partners".
NEU Price at posting:
17.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)